NEW YORK, Feb. 19, 2014 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Cadence Pharmaceuticals, Inc. ("CADX") to Mallinckrodt plc in a cash transaction...